GeneDx AI

Company profile

About GeneDx AI

GeneDx is a leading provider of advanced genetic testing and genomic sequencing for rare and complex disease diagnosis. The company specializes in whole exome sequencing (ExomeDx™) and whole genome sequencing (GenomeDx™), offering comprehensive analysis across approximately 20,000 genes to help clinicians deliver faster, more accurate diagnoses for patients with suspected genetic conditions. GeneDx has performed over 2.5 million genetic tests, including nearly 1 million exomes and genomes sequenced, creating one of the largest rare disease datasets in the world—GeneDx Infinity™. This dataset, combined with 8 million phenotypic data points, fuels deeper diagnostic insights and enables precision medicine. The company serves multiple stakeholders including healthcare providers, patients and families, health systems, and biopharma companies. GeneDx's testing portfolio addresses a wide range of conditions including neurodevelopmental disorders, epilepsy, autism spectrum disorder, cerebral palsy, congenital heart disease, global developmental delay, intellectual disability, and neonatal/pediatric critical care conditions. The company offers rapid and ultra-rapid testing options, with results available within days or weeks, and accepts simple cheek swabs for most tests with at-home sample collection available. GeneDx is recognized as the #1 genetic test by pediatric and genetic specialists, with diagnostic yield 17% greater than standard testing. The company is an in-network provider for 79% of commercially insured patients across the U.S., with Medicaid coverage available in 36 states, and offers a Financial Assistance Program to reduce out-of-pocket costs. GeneDx integrates with Epic Aura EHR systems and provides comprehensive support including genetic counseling, clearly written reports, and educational resources for clinicians and families.

Company description · GeneDx AI official website